Chronogen raises $3,275,000

Chronogen, a privately-owned biotechnology company, headquartered in Montreal and developing innovative small-molecule drugs to treat age-related diseases, announced today that it has secured a US$ 3.275 million venture loan from MMV Financial Inc. to support the continuing growth of the company.